Carter Todd Alfred's Form 4 filing
Voyager Therapeutics, Inc. (VYGR) · filed Jul 10, 2023
- Accession no.
- 0001104659-23-079686
- Filed
- Jul 10, 2023
- Trade date
- Jul 6, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $59.4K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Carter Todd AlfredCIK 0001944011 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 6, 2023 | Common Stock | SSaleDisposed | −5,500 | $10.80 | −$59,400 | 59,860 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.